Sangamo Biosciences, Inc. (SGMO) Tops Q2 EPS by 3c

Sangamo Biosciences, Inc. (NASDAQ: SGMO) reported Q2 EPS of ($0.10), $0.03 better than the analyst estimate of ($0.13). Revenue for the quarter came in at $6.93 million versus the consensus estimate of $4.77 million.

For earnings history and earnings-related data on Sangamo Biosciences, Inc. (SGMO) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Paychex (PAYX) Tops Q1 EPS by 2c
• Cintas Corp. (CTAS) Tops Q1 EPS by 1c, Offers Guidance
• Interactive Strength reports record Q2 results, raises Q3 guidance